ILC-UK and IFA issue joint statement on proposed childhood pneumococcal vaccine changes
As organisations concerned with the current and future wellbeing of our rapidly ageing society, the International Longevity Centre – UK (ILC-UK) and the International Federation on Ageing (IFA) have conducted a great deal of work on the burden of pneumococcal disease across the life-course.
We believe that the UK’s immunisation programme over recent years has been very successful in reducing incidences of Invasive Pneumococcal Disease (IPD), a major cause of death globally.
However, in October 2017 the Joint Committee on Vaccination and Immunisation (JCVI) suggested that the childhood vaccination for pneumococcal disease should move from a 2+1 schedule (two initial doses and a follow-up dose) to a 1+1 schedule (one initial dose and a follow-up).
We were concerned to hear from the JCVI’s reports that “moving to a 1+1 schedule might increase IPD cases in infants because of loss of direct protection, and in older adults because of a reduction in herd immunity as a result of less protection against carriage in infants after a single dose.”
We would welcome more detailed research into the potential increase in cases of invasive pneumococcal disease in children and adults that might occur from a change to the pneumococcal immunisation programme, to a ‘1 + 1’ schedule.
Given the potential risks of this decision, we would urge a fuller consultation on proposed changes to the pneumococcal immunisation programme. Perhaps an expert sub-committee of JCVI could be convened to review the evidence before a final decision is made.
Finally, to declare an interest, ILC-UK’s work on immunisation has been financially supported (through non-restricted educational grants) by a range of pharmaceutical companies who may have an interest in this area including SPMSD, Eli Lilly, and Pfizer and the IFA’s work on immunisation has been supported similarly by Pfizer and GSK through unrestricted educational grants.
David Sinclair Jane Barratt
Director Secretary General
ILC-UK International Federation on Ageing
Date :28 January 2018
ILC-UK are once again looking for someone to speak for 10 minutes on the plenary platform in front of 250 people at our annual Future of Ageing Conference (29th November, London).
Date :03 August 2018
“Auto-enrolment has successfully led to millions more saving each month towards a pension, but the Committee is right to call for action to get people saving more. We are pleased they support our recommendations to consider automatic escalation of pension contributions for some individuals, and we agree that a strategy is needed to automatically-enrol the self-employed."
Date :27 July 2018
Dr Brian Beach, Senior Research Fellow at ILC-UK and who gave oral evidence to the Committee, welcomes the Committee’s call for stronger action by Government and EHRC and says it’s crucial that employers understand what ageism really is.
Date :17 July 2018
Press Release: Leading think tank responds to OBR report on the impact of population ageing
“The latest Fiscal Sustainability Report makes it very clear that we are facing an uncertain future. Demographic pressures are set to continue to dominate the agenda, with health, pension and adult social care spending all set to rise as a proportion of total GDP."
Date :17 July 2018
Recruitment - ILC-UK are recruiting for a paid Summer Intern
Are you looking for a short-term paid role in a think tank over the summer?
The independent think tank the International Longevity Centre – UK (ILC-UK) is seeking a summer intern to start on Monday 23 July. The intern would work 4 days a week for a period of 4 weeks, with the possibility of extension.
Date :10 July 2018
Press Release: Flu vaccine saves millions in averted lost employment and lost informal care
New research ‘An Economic Analysis of Flu Vaccination’ paints a picture of lives saved and costs averted, but more needs to be done to increase uptake
Date :05 July 2018
